Myocardial Fibrosis and Inflammation in Liver Cirrhosis

CompletedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

November 2, 2018

Primary Completion Date

January 5, 2021

Study Completion Date

September 8, 2021

Conditions
Cirrhosis, LiverCardiomyopathiesPortal Hypertension
Interventions
PROCEDURE

Transjugular intrahepatic portosystemic shunt implantation

Transjugular intrahepatic portosystemic shunt is an artificial channel within the liver that establishes communication between the inflow portal vein and the outflow hepatic vein. It is used to treat portal hypertension (e.g., in liver cirrhosis)

DIAGNOSTIC_TEST

Magnetic resonance imaging

Multiparametric cardiac and hepatic magnetic resonance imaging

Trial Locations (2)

53127

University Hospital Bonn, Clinic for Diagnostic and Interventional Radiology, Bonn

University Hospital Bonn, Medical Clinic and Polyclinic I, Bonn

All Listed Sponsors
lead

University Hospital, Bonn

OTHER

NCT05047029 - Myocardial Fibrosis and Inflammation in Liver Cirrhosis | Biotech Hunter | Biotech Hunter